Alagille Syndrome

Odevixibat shows promise for Alagille syndrome in ASSERT study

Odevixibat is an effective and safe non-surgical treatment for reducing pruritus and serum bile acids in patients with Alagille syndrome (ALGS), according to results of a Phase 3 study. In the ASSERT study, 52 patients with ALGS were randomized to receive either odevixibat or a placebo for 24 weeks. The...